US 8450341
Substituted indolin-2-one derivatives and their use as P38 mitogen-activated kinase inhibitors
granted A61PA61P1/00A61P1/04
Quick answer
US patent 8450341 (Substituted indolin-2-one derivatives and their use as P38 mitogen-activated kinase inhibitors) held by Almirall, S.A. expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Almirall, S.A.
- Grant date
- Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P11/00, A61P11/16